AOD-9604 (5 mg)

Research use only

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to amino acids 177–191. Unlike full-length hGH, AOD-9604 is designed to retain fat-reducing properties without affecting insulin sensitivity or inducing growth-promoting activity. Preclinical studies show that AOD-9604 stimulates lipolysis, inhibits lipogenesis, and may enhance fat oxidation. This makes it a valuable tool for exploring obesity, metabolic disorders, and energy regulation in experimental models.

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to amino acids 177–191. Unlike full-length hGH, AOD-9604 is designed to retain fat-reducing properties without affecting insulin sensitivity or inducing growth-promoting activity. Preclinical studies show that AOD-9604 stimulates lipolysis, inhibits lipogenesis, and may enhance fat oxidation. This makes it a valuable tool for exploring obesity, metabolic disorders, and energy regulation in experimental models.

Technical data Dose 10 mg, 5 mg

Supplied as a lyophilized powder in vials (5 mg). Store at –20 °C, protected from light and moisture. After reconstitution in sterile water or buffer, aliquot and store at 2–8 °C for short-term use or –20 °C for long-term preservation. Avoid repeated freeze–thaw cycles to maintain integrity.

Supplied as a lyophilized powder in vials (5 mg). Store at –20 °C, protected from light and moisture. After reconstitution in sterile water or buffer, aliquot and store at 2–8 °C for short-term use or –20 °C for long-term preservation. Avoid repeated freeze–thaw cycles to maintain integrity.

For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

Frequently bought together: BPC-157 (5 mg, 10 mg), CJC-1295 no DAC (5mg), DSIP (5 mg)